Izotropic Announces Debt Settlement
British Columbia and Sacramento, California--(Newsfile Corp. - April 21, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has entered into a debt settlement agreement (the "Agreement") with a lender (the "Le
2026-04-21 2:09 PM EDT | Izotropic Corporation
Microbiome Labs relaunches BiomeFX to advance gut microbiome interpretation
Franklinton, North Carolina--(Newsfile Corp. - April 21, 2026) - Microbiome Labs™, a leader in microbiome-based solutions, today announced the relaunch of its BiomeFX™ Functional Microbiome Analysis in partnership with Jona, the AI-powered gut microbiome company. The interpretation layer of BiomeFX is now powered by Jona AI, a clinical-grade microbiome anal
2026-04-21 9:00 AM EDT | Microbiome Labs
Gregory Esemplare Appointed Chief Operating Officer of HarmonyRx
New York, New York--(Newsfile Corp. - April 21, 2026) - HarmonyRx today announced the appointment of Gregory Esemplare as Chief Operating Officer (COO). In this role, Greg will oversee operations across the organization, with a focus on driving alignment, enhancing execution and supporting continued growth in pharmacy benefits. Greg brings extensive experience in healthcare services, pharmacy benefits and client-focused operations. He previously served in a senior le
2026-04-21 8:25 AM EDT | HarmonyRx
WELL Health Reports Record Canadian Patient Visits and Primary Care Margin Expansion in Q1-2026
WELL Canada delivered a record ~1.27 million patient visits(1) in Q1-2026, representing 33% year-over-year growth and 13% organic growth, reflecting broad-based strength across its national network. Primary Care Adjusted EBITDA(2) margins expanded to approximately 8% in Q1-2026 on a preliminary basis, up approximately 200 basis points from 6% in Q1-2025, driven by WELL's clinic transformation program and re
Technologies, Logiciels, Soins de santé et hôpitaux, Santé
2026-04-21 7:00 AM EDT | WELL Health Technologies Corp.
The Longevity Investors Conference Announces 2026 Speaker Lineup Featuring Dave Asprey, Dr. Steve Horvath, Garri Zmudze and More
Zug, Switzerland--(Newsfile Corp. - April 20, 2026) - The Longevity Investors Conference (LIC), the world's most private gathering at the intersection of longevity science and capital, returns for its seventh annual edition, taking place September 14-17, 2026 at Le Grand Bellevue in Gstaad, Switzerland. With a 20% acceptance rate, a place at LIC is among the most sought-after in the longevity investment world - and Early Bird pricing closes May 31.
2026-04-20 1:55 PM EDT | Longevity Investors AG
LevelJump Closes Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce that, further to its news release of April 7, 2026, it has closed, effective as of April 16, 2026, a non-brokered private placement (the "Offering") through the issuance of 14,380,000 common shares (the "Offered Shares") at a price of C$0.05 per Offered Share in the capital of the Company for gross proceeds of C$719,000. All sec
Soins de santé et hôpitaux, Santé
2026-04-20 12:12 PM EDT | LevelJump Healthcare Corp.
Nualtis Corp. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Montreal, Quebec--(Newsfile Corp. - April 20, 2026) - Nualtis Corp., a specialty pharmaceutical company focused on the development of innovative oral dissolvable film (ODF) drug delivery technologies, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-20 11:41 AM EDT | Bloom Burton & Co. Inc.
LIS Technologies Inc. Announces Opening Keynote Presentation and Platinum Sponsorship of Reuters Events' SMR and Advanced Reactor 2026 Conference
Oak Ridge, Tennessee--(Newsfile Corp. - April 20, 2026) - LIS Technologies Inc. ("LIST" or "the Company"), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, is pleased to announce its Platinum Sponsorship of the upcoming Reuters Events' SMR and Advanced Reactor 2026 Conference, Held in Austin, Texas on May 11-12, 2026. Christo Liebenberg, President and Co-Founder of LIS Technologies, will lead the event's D
Technologies, Mines et métaux, Énergie, Santé
2026-04-20 8:59 AM EDT | LIS Technologies Inc.
Orange Auto Insurance, Inc., Subsidiary of HPN Holdings, Inc. Announces Formation of its Strategic Advisory Board
Chicago, Illinois--(Newsfile Corp. - April 20, 2026) - HPN Holdings, Inc. (OTCID: KICK) ("HPN" or the "Company") today announced that its subsidiary Orange Auto Insurance, Inc ("Orange"), a managing general agency focused on delivering technology-driven automobile insurance solutions, today announced the formation of its Strategic Advisory Board, bringing together a group of experienced industry leaders to support the company's next phase of growth. The Advisory Board will provide guid
2026-04-20 8:55 AM EDT | HPN Holdings, Inc.
Numinus Wellness Responds to Trump Executive Order on Psychedelic Therapies
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Numinus Wellness Inc. (OTC: NUMIF) today acknowledged the Executive Order signed by President Donald J. Trump directing United States federal agencies to accelerate research, access, and regulatory review for psychedelic-based treatments, including psilocybin, ibogaine, MDMA, and LSD. The Order directs the FDA to prioritize review of psychedelics with Breakthrough Therapy designation, establishes new investigational acces
2026-04-20 8:30 AM EDT | Numinus Wellness Inc.
Red Light Holland Highlights U.S. FDA-Authorized Study Supporting Multi-Session Psilocybin Therapy using Filament Health's Patented PEX010 Botanical Drug Candidate
Study conducted under U.S. FDA Investigational New Drug (IND) authorization by Dr. Anthony Back at the University of Washington Second psilocybin session showed meaningful improvements in anxiety, depression, and overall psychological outcomes, with effects lasting up to 24 weeks 69% of participants fell below clinical thresholds for anxiety and depression after second treatment Research builds on prior studies utilizing Filament's botanica
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-04-20 7:30 AM EDT | Red Light Holland Corp.
Yellowbird Diagnostics to Present at the Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - Yellowbird Diagnostics Inc. a clinical-stage biotechnology company developing next-generation metabolic imaging agents to detect disease earlier and guide clinical decision-making, today announced that it will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada. Nick Calvert, Chief Executive Officer, and Michael Gottlieb, Ex
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-20 7:15 AM EDT | Bloom Burton & Co. Inc.
Rise Nano Optics Announces Strategic Partnership with Sierra Optical Lab to Produce and Commercialize SpectraGuard(TM) Lenses in the United States
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced a strategic partnership with Sierra Optical Lab ("Sierra Optical"), an independent wholesale optical laboratory and VSP®-Authorized Lab, located in Reno, Nevada, to support the production and commercialization of its SPECTRAGUA
2026-04-20 7:00 AM EDT | Rise Nano Optics Ltd.
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today launched its Ibogaine Initiative, a program to extend the Company's Health Canada-licensed GMP platform to include the manufacture and supply of ibogaine. The initiative comes as the United States has, for the first time, taken ini
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-20 6:00 AM EDT | Optimi Health Corp.
Optimi Health startet Ibogaine-Initiative, da US-Executive Order einen Weg für psychedelische Arzneimittelprodukte signalisiert
Vancouver, British Columbia--(Newsfile Corp. - Montag, 20. April 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (das "Unternehmen" oder "Optimi"), ein kommerziell tätiger pharmazeutischer Hersteller regulierter psychedelischer Arzneimittelprodukte, gab heute den Start seiner Ibogaine-Initiative bekannt. Ziel des Programms ist es, die nach GMP lizenzierte Plattform des Unternehmens mit Health-Canada-Zulassung auf die Herstellung und Lieferung von Ibogaine auszuwe
Biotechnologies, Pharmaceutique, Santé, Psychédéliques
2026-04-20 2:00 AM EDT | Optimi Health Corp.
Northwyn Wellness Group Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2026) - Northwyn Wellness Group, Canada's operator-led platform for medical aesthetics, dermatology, preventative medicine, and wellness clinics, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-19 6:00 PM EDT | Bloom Burton & Co. Inc.
Unbuzzd Wellness Announces Resignation of Chief Executive Officer
Vancouver, British Columbia--(Newsfile Corp. - April 17, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™,the scientifically-proven beverage proven to accelerate alcohol metabolism, restore mental clarity, and reduce hangover symptoms, announces today that John Duffy has resigned from his position as Chief Executive Officer of the Company, effective as of the date hereof. The Company thanks Mr. Duffy for his contributions and wi
2026-04-17 5:00 PM EDT | Unbuzzd Wellness Inc.
Richards Group Inc. Announces Participation in The 2026 Bloom Burton & Co. Healthcare Investor Conference
Mississauga, Ontario--(Newsfile Corp. - April 17, 2026) - Richards Group Inc. (TSX: RIC) will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre.
Technologies, Biotechnologies, Services bancaires d’investissement, Santé
2026-04-17 1:32 PM EDT | Bloom Burton & Co. Inc.
All Star Health Brands (ALST) Explores Acquisition of Resort Property in Sanremo to Expand Future Soccer Programs
Toronto, Ontario--(Newsfile Corp. - April 17, 2026) - ALST (OTCID: ALST) today announced it is actively exploring the potential acquisition of a resort property in Sanremo, Italy, as part of a strategic initiative to expand its long-term investment in soccer development programs. The proposed acquisition reflects ALST's commitment to fostering athletic excellence, youth development, and international sports collaboration. The Sanremo location, known for its coastal setting and establish
Soins de santé et hôpitaux, Commerce de détail, Santé
2026-04-17 8:00 AM EDT | Allstar Health Brands, Inc.
Functional Brands Inc. Unveils New Weight Loss Support Bundle to Boost Digestion, Metabolism, and Muscle Preservation
Lake Oswego, Oregon--(Newsfile Corp. - April 17, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced the launch of its new Kirkman Weight Loss Support Bundle. Designed to support a healthy and sustainable weight loss journey, this bundle combines three scientifically-backed products to target key areas of digestion, metabolism, and muscle preservation. The Weight Loss Support Bundle includes:
Produits ménagers / de consommation / cosmétiques, Santé
2026-04-17 8:00 AM EDT | Functional Brands Inc.